Racial Differences in Survival Among Men With Prostate Cancer and Comorbidity at Time of Diagnosis
Vincent L. Freeman, MD, MPH,
Ramon Durazo-Arvizu, PhD,
LaShon C. Keys, MEd, RD,
Marc P. Johnson, BA,
Kristian Schafernak, MD, MPH and
Vikas K. Patel, MD
Vincent L. Freeman is with the Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, Hines, Ill. Vincent L. Freeman, Marc P. Johnson, Kristian Schafernak, and Vikas K. Patel are with the Department of Medicine, Loyola University Stritch School of Medicine, Maywood, Ill. Ramon Durazo-Arvizu is with the Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Ill. LaShon C. Keys is with the Division of Community Health and Prevention, Illinois Department of Human Services, Tinley Park, Ill.
FIGURE 1—Ninety-five percent bootstrap confidence intervals for cause-specific mortality rates of Blacks relative to Whites, by Charlson comorbidity score.